Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 369, Issue 3, 2004, Pages 294-299

  Costa, Barbara ^a   Colleoni, Mariapia ^b   Conti, Silvia ^a   Parolaro, Daniela ^c   Franke, Chiara ^b   Trovato, Anna Elisa ^a   Giagnoni, Gabriella ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Cannabidiol; Cannabinoids; Carrageenan; COX system; Hyperalgesia; Inflammation; NO system

Indexed keywords

CANNABIDIOL; CANNABIS; CARRAGEENAN; MALONALDEHYDE; NITRIC OXIDE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE;

ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; HORMONE BLOOD LEVEL; HYPERALGESIA; LIPID PEROXIDATION; MALE; NONHUMAN; PAW EDEMA; PROTEIN EXPRESSION; RAT; SYMPTOM; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CANNABIDIOL; CANNABIS; CARRAGEENAN; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; HYPERALGESIA; MALE; NITRIC OXIDE; RATS; RATS, WISTAR;

EID: 1642268380     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-004-0871-3     Document Type: Article

References (34)

1. Agha A, Gad MZ (1995) Lipid peroxidation and lysosomal integrity in different inflammatory models in rats: the effects of indomethacin and naftazone. Pharmacol Res 32:279-285
2. Beckman JS, Beckman TW, Chen TW, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implication of endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620-1624
3. Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, Moriello AS, Davis JB, Mechoulam R, Di Marzo V (2001) Molecular target for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol 134:845-852
4. Claxson A, Morris C, Blake D, Siren M, Halliwell B, Gustafsson T, Lofkvist B, Bergelin I (1990) The anti-inflammatory effects of D-myoinositol-1,2,6-triphosphate (PP56) on animal models of inflammation. Agents Actions 29:68-70
5. Coffey RG, Yamamoto Y, Snella E, Pross S (1996) Tetrahydrocannabinol inhibition of macrophage nitric oxide production. Biochem Pharmacol 52:743-751
6. Conti S, Costa B, Colleoni M, Parolaro D, Giagnoni G (2002) Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. Br J Pharmacol 135:181-187
7. Costa B, Conti S, Giagnoni G, Colleoni M (2002) Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems. Br J Pharmacol 137:413-420
8. Di Rosa M, Willoughby DA (1971) Screens for anti-inflammatory drugs. J Pharm Pharmacol 23:297-300
9. Evans FJ (1991) Cannabinoids: the separation of central from peripheral effects on a structural basis. Planta Med 57 [Suppl]:60-67
10. Formukong EA, Evans AT, Evans FJ (1988) Analgesic and anti-inflammatory activity of constituents of Cannabis sativa L. Inflammation 12:361-371
11. Gierse JK, Koboldt CM, Walker MC, Siebert K, Isakson PC (1999) Kinetic basis for selective inhibition of cyclo-oxygenase. Biochem J 339:607-614
12. Griffiths HR, Dowling EJ, Sahinoglu T, Blake DR, Parnham M, Lunec J (1992) The selective protection afforded by ebselen against lipid peroxidation in a ROS-dependent model of inflammation. Agents Actions 36:107-111
13. 9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci USA 95:8268-8273
14. Handy RL, Moore PK (1998) A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity. Br J Pharmacol 123:1083-1088
15. Hargreaves K, Dubner R, Brown F, Flores C, Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77-98
16. Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, Feldmann M (2000) The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci USA 97:9561-9566
17. Mechoulam R (1986) The pharmacohistory of Cannabis sativa. In: Mechoulam R (ed) Cannabinoids as therapeutic agents. CRC, Boca Raton, pp 1-19
18. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG (1993) A fluorimetric assay for the measurement of nitrite in biological samples. Anal Biochem 214:11-16
19. Nakamura M, Ferreira SH (1987) A peripheral sympathetic component in inflammatory hyperalgesia. Eur J Pharmacol 135:145-153
20. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358
21. Radi R, Beckman JS, Bush KM, Freeman BA (1991) Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 288:481-487
22. Razdan RK (1986) Structure activity relationships in cannabinoids. Pharmacol Rev 38:75-149
23. Rubbo H, Radi R, Trujillo M, Teilen R, Kalyanaraman B, Barnes S, Kirk M, Freeman BA (1994) Nitric oxide regulation of superoxide and peroxynitrite- dependent lipid peroxidation. J Biol Chem 269:26066-26075
24. Salvemini D, Wang ZQ, Bourdon DM, Stern MK, Currie MG, Manning PT (1996a) Evidence of peroxynitrite involvement in the carrageenan-induced rat paw edema. Eur J Pharmacol 303:217-220
25. Salvemini D, Wang ZQ, Wyatt PS, Bourdon DM, Marino MH, Manning PT, Currie MG (1996b) Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation. Br J Pharmacol 118:829-838
26. Sanders J, Jackson DM, Starmer GA (1979) Interactions among the cannabinoids in the antagonism of the abdominal constriction response in the mouse. Psychopharmacology 61:281-285
27. Showalter VM, Compton DR, Martin BR, Abood ME (1996) Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 264:463-468
28. Sofia RD, Knobloch LC, Vassar HB (1973) The anti-edema activity of various naturally occurring cannabinoids. Res Commun Chem Pathol Pharmacol 6:909-918
29. Sofia RD, Vassar HB, Knobloch LC (1975) Comparative analgesic activity of various naturally occurring cannabinoids in mice and rats. Psychopharmacologia 40:285-295
30. Srivastava MD, Srivastava BI, Brouhard B (1998) Delta-9- tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells. Immunopharmacology 40:179-185
31. Symons AM, Dowling EJ, Parke DV (1988) Lipid peroxidation, free radicals and experimental inflammation. Basic Life Sci 49:987-990
32. Tracey WR, Nakane M, Kuk J, Budzig G, Klinghofer V, Harris R, Cartel G (1995) The nitric oxide synthase inhibitor, L-NG-monomethylarginine, reduces carrageenan-induced pleurisy in the rat. J Pharmacol Exp Ther 273:1295-1299
33. Watzl B, Scuderi P, Watson RR (1991) Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon gamma and suppress interleukin-1 alpha in vitro. Int J Immunopharmacol 13:1091-1097
34. Yoshikawa T, Kondo M (1981) In: Goto Y, Yagi K (eds) Lipid peroxide and disease. Igaku-shoin, Tokyo, p 210